glp 1 health concerns The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 GLP-1 Agonist: The Good, the

They just went back to the old way of managing it

While GLP-1 agonists have demonstrated significant benefits for glycemic control and weight management, patients and clinicians must consider potential interactions with thyroid function and the specific considerations relevant to autoimmune thyroid disease

Clinical trials demonstrate that higher doses generally produce greater weight reduction, but individual responses vary considerably

These FDA-approved treatments help regulate appetite, improve blood sugar control, and support sustainable weight loss

Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice

Deanfield, J., et al